174 related articles for article (PubMed ID: 26220616)
41. Measurement of neutral ceramidase activity in vitro and in vivo.
Simoes M; Saleh A; Choi YM; Airola MV; Haley JD; Coant N
Anal Biochem; 2022 Apr; 643():114577. PubMed ID: 35134389
[TBL] [Abstract][Full Text] [Related]
42. Purification and characterization of human intestinal neutral ceramidase.
Ohlsson L; Palmberg C; Duan RD; Olsson M; Bergman T; Nilsson A
Biochimie; 2007 Aug; 89(8):950-60. PubMed ID: 17475390
[TBL] [Abstract][Full Text] [Related]
43. A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity.
He X; Li CM; Park JH; Dagan A; Gatt S; Schuchman EH
Anal Biochem; 1999 Oct; 274(2):264-9. PubMed ID: 10527524
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of ceramide-containing endocytotic vesicles in human diploid fibroblasts.
Sutrina SL; Chen WW
J Biol Chem; 1982 Mar; 257(6):3039-44. PubMed ID: 7061463
[TBL] [Abstract][Full Text] [Related]
45. An Arabidopsis neutral ceramidase mutant ncer1 accumulates hydroxyceramides and is sensitive to oxidative stress.
Li J; Bi FC; Yin J; Wu JX; Rong C; Wu JL; Yao N
Front Plant Sci; 2015; 6():460. PubMed ID: 26150824
[TBL] [Abstract][Full Text] [Related]
46. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway.
Sasaki H; Toyomura K; Matsuzaki W; Okamoto A; Yamaguchi N; Nakamura H; Murayama T
Arch Biochem Biophys; 2014 May; 550-551():12-9. PubMed ID: 24708996
[TBL] [Abstract][Full Text] [Related]
47. Development of a novel FRET probe for the real-time determination of ceramidase activity.
Bhabak KP; Hauser A; Redmer S; Banhart S; Heuer D; Arenz C
Chembiochem; 2013 Jun; 14(9):1049-52. PubMed ID: 23728798
[TBL] [Abstract][Full Text] [Related]
48. Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes.
Raisova M; Goltz G; Bektas M; Bielawska A; Riebeling C; Hossini AM; Eberle J; Hannun YA; Orfanos CE; Geilen CC
FEBS Lett; 2002 Apr; 516(1-3):47-52. PubMed ID: 11959101
[TBL] [Abstract][Full Text] [Related]
49. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
50. Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis.
Cho SM; Kwon HJ
Arch Pharm Res; 2019 Mar; 42(3):232-243. PubMed ID: 30661200
[TBL] [Abstract][Full Text] [Related]
51. Sphingolipid modulation: a strategy for cancer therapy.
Delgado A; Fabrias G; Bedia C; Casas J; Abad JL
Anticancer Agents Med Chem; 2012 May; 12(4):285-302. PubMed ID: 21864240
[TBL] [Abstract][Full Text] [Related]
52. Citric acid inhibits a bacterial ceramidase and alleviates atopic dermatitis in an animal model.
Inoue H; Someno T; Kawada M; Ikeda D
J Antibiot (Tokyo); 2010 Oct; 63(10):611-3. PubMed ID: 20648022
[No Abstract] [Full Text] [Related]
53. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
54. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
55. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
Vijayan Y; Lankadasari MB; Harikumar KB
Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of sphingosine is essential for oxidative stress-induced apoptosis of photoreceptors.
Abrahan CE; Miranda GE; Agnolazza DL; Politi LE; Rotstein NP
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1171-80. PubMed ID: 19797232
[TBL] [Abstract][Full Text] [Related]
57. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
58. Gene cloning of a neutral ceramidase from the sphingolipid metabolic pathway based on transcriptome analysis of Amorphophallus muelleri.
Zhong L; Liu E; Yang C; Diao Y; Harijati N; Liu J; Hu Z; Jin S
PLoS One; 2018; 13(3):e0194863. PubMed ID: 29590184
[TBL] [Abstract][Full Text] [Related]
59. Targeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes.
Li WH
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144859
[TBL] [Abstract][Full Text] [Related]
60. Distribution and properties of neutral ceramidase activity in rat intestinal tract.
Lundgren P; Nilsson A; Duan RD
Dig Dis Sci; 2001 Apr; 46(4):765-72. PubMed ID: 11330410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
